RhumbLine Advisers’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$53.3M Buy
243,720
+6,923
+3% +$1.51M 0.05% 331
2025
Q1
$53M Buy
236,797
+17,711
+8% +$3.97M 0.05% 318
2024
Q4
$71.8M Buy
219,086
+32
+0% +$10.5K 0.06% 247
2024
Q3
$65.8M Buy
219,054
+1,245
+0.6% +$374K 0.06% 272
2024
Q2
$71.7M Buy
217,809
+4,822
+2% +$1.59M 0.07% 240
2024
Q1
$84.3M Buy
212,987
+7,074
+3% +$2.8M 0.08% 219
2023
Q4
$72.5M Sell
205,913
-3,522
-2% -$1.24M 0.08% 228
2023
Q3
$78.6M Sell
209,435
-1,106
-0.5% -$415K 0.09% 195
2023
Q2
$80.5M Buy
210,541
+2,305
+1% +$882K 0.09% 196
2023
Q1
$72.1M Sell
208,236
-1,690
-0.8% -$586K 0.09% 211
2022
Q4
$49.4M Buy
209,926
+7,783
+4% +$1.83M 0.07% 274
2022
Q3
$49.7M Buy
202,143
+4,743
+2% +$1.17M 0.07% 247
2022
Q2
$59.7M Buy
197,400
+11,202
+6% +$3.39M 0.09% 207
2022
Q1
$76.5M Buy
186,198
+2,679
+1% +$1.1M 0.1% 181
2021
Q4
$86.1M Buy
183,519
+25,770
+16% +$12.1M 0.11% 164
2021
Q3
$67M Sell
157,749
-2,220
-1% -$942K 0.09% 191
2021
Q2
$57.4M Sell
159,969
-5,176
-3% -$1.86M 0.08% 232
2021
Q1
$46.5M Sell
165,145
-3,192
-2% -$899K 0.06% 265
2020
Q4
$47.7M Sell
168,337
-24,758
-13% -$7.01M 0.07% 253
2020
Q3
$53.1M Sell
193,095
-27,670
-13% -$7.61M 0.08% 213
2020
Q2
$50.2M Sell
220,765
-37,094
-14% -$8.43M 0.08% 206
2020
Q1
$39.3M Buy
257,859
+13,005
+5% +$1.98M 0.08% 217
2019
Q4
$36.8M Sell
244,854
-1,020
-0.4% -$153K 0.06% 290
2019
Q3
$34.9M Sell
245,874
-3,257
-1% -$462K 0.06% 277
2019
Q2
$31.2M Buy
249,131
+11,018
+5% +$1.38M 0.06% 308
2019
Q1
$26.2M Sell
238,113
-11,039
-4% -$1.22M 0.05% 340
2018
Q4
$24.4M Buy
249,152
+63,381
+34% +$6.21M 0.05% 332
2018
Q3
$22.9M Buy
185,771
+5,710
+3% +$705K 0.04% 398
2018
Q2
$17.9M Sell
180,061
-7,836
-4% -$778K 0.04% 475
2018
Q1
$16.6M Buy
187,897
+15,558
+9% +$1.37M 0.03% 489
2017
Q4
$17M Sell
172,339
-9,703
-5% -$957K 0.03% 492
2017
Q3
$17.5M Buy
182,042
+18,477
+11% +$1.78M 0.04% 467
2017
Q2
$15.5M Buy
163,565
+2,888
+2% +$273K 0.04% 487
2017
Q1
$13.1M Buy
160,677
+4,362
+3% +$356K 0.03% 549
2016
Q4
$13.3M Buy
156,315
+7,020
+5% +$595K 0.03% 511
2016
Q3
$11.1M Buy
149,295
+8,974
+6% +$669K 0.03% 531
2016
Q2
$10.6M Sell
140,321
-9,884
-7% -$750K 0.03% 519
2016
Q1
$10.4M Sell
150,205
-39,570
-21% -$2.74M 0.03% 521
2015
Q4
$11.4M Buy
189,775
+3,100
+2% +$187K 0.04% 466
2015
Q3
$10.1M Buy
186,675
+33,325
+22% +$1.8M 0.03% 502
2015
Q2
$8.91M Sell
153,350
-6,020
-4% -$350K 0.03% 564
2015
Q1
$9.6M Buy
159,370
+5,860
+4% +$353K 0.03% 548
2014
Q4
$8.17M Sell
153,510
-5,314
-3% -$283K 0.02% 567
2014
Q3
$7.11M Buy
158,824
+11,675
+8% +$523K 0.02% 595
2014
Q2
$6.21M Sell
147,149
-6,321
-4% -$267K 0.02% 696
2014
Q1
$6.76M Sell
153,470
-16,934
-10% -$746K 0.02% 670
2013
Q4
$8.36M Buy
170,404
+910
+0.5% +$44.6K 0.02% 567
2013
Q3
$6.98M Buy
169,494
+48,578
+40% +$2M 0.02% 653
2013
Q2
$4.25M Buy
+120,916
New +$4.25M 0.01% 849